Does EMPAGLIFLOZIN\LINAGLIPTIN Cause Interstitial lung disease? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with EMPAGLIFLOZIN\LINAGLIPTIN. This represents 0.3% of all adverse event reports for EMPAGLIFLOZIN\LINAGLIPTIN.
5
Reports of Interstitial lung disease with EMPAGLIFLOZIN\LINAGLIPTIN
0.3%
of all EMPAGLIFLOZIN\LINAGLIPTIN reports
1
Deaths
2
Hospitalizations
How Dangerous Is Interstitial lung disease From EMPAGLIFLOZIN\LINAGLIPTIN?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN\LINAGLIPTIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN\LINAGLIPTIN Cause?
Diabetic ketoacidosis (149)
Blood glucose increased (121)
Fungal infection (92)
Weight decreased (77)
Nausea (68)
Dizziness (58)
Vomiting (55)
Urinary tract infection (52)
Euglycaemic diabetic ketoacidosis (49)
Dehydration (44)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which EMPAGLIFLOZIN\LINAGLIPTIN Alternatives Have Lower Interstitial lung disease Risk?
EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL